Edit

Emmaus Life Sciences Inc.

http://www.emmausmedical.com/

Last activity: 12.10.2021

Tags:DevelopmentLife

Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.

Mentions

Employees: 51-200

Founded date: 2000

Investors 1

Date	Name	Website
-	E&Inve...	eninvestme...

Mentions in press and media 17

Date	Title	Description	Source
12.10.2021	Emmaus Life Sciences : Acquires Key Intellectual Property Ri...	Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in...	marketscre...
17.08.2021	Emmaus Life Sciences Announces Bahrain Temporary License of ...	TORRANCE, Calif., Aug. 17, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commerci...	prnewswire...
17.08.2021	Emmaus Life Sciences : Announces Bahrain Temporary License o...	TORRANCE California, August 17, 2021 - Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage bi...	marketscre...
15.07.2021	Emmaus Life Sciences : Announces Submission of Endari Market...	TORRANCE California, July 15, 2021 - Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biop...	marketscre...
15.06.2021	Emmaus Life Sciences Announces Submission of Marketing Autho...	TORRANCE, Calif., June 15, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commerci...	prnewswire...
15.06.2021	EMMAUS LIFE SCIENCES, INC. Emmaus Life Sciences : Announces...	Torrance CA, June 15, 2021 - Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceu...	marketscre...
26.05.2021	EMMAUS LIFE SCIENCES, INC. Emmaus Life Sciences : Announces...	TORRANCE California, May 26, 2021 - Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage bioph...	marketscre...
26.05.2021	Emmaus Life Sciences Announces Submission of Marketing Autho...	TORRANCE, Calif., May 26, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commercia...	prnewswire...
04.05.2021	Emmaus Life Sciences Reports Annual Financial Results for 20...	TORRANCE, Calif., May 4, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial...	prnewswire...
04.05.2021	Emmaus Life Sciences : Reports Annual Financial Results for ...	-- Net Revenues Increased Despite COVID-19 Pandemic-Related Challenges -- -- Improved Overall Opera...	marketscre...
04.05.2021	EMMAUS LIFE SCIENCES, INC. Emmaus Life Sciences : Reports A...	-- Net Revenues Increased Despite COVID-19 Pandemic-Related Challenges -- -- Improved Overall Opera...	marketscre...
02.03.2021	Emmaus Life Sciences Announces Collaboration with Kainos Med...	TORRANCE, Calif., March 2, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a commerci...	prnewswire...
25.01.2021	Emmaus Life Sciences Reports Annual Financial Results for 20...	TORRANCE, Calif., Jan. 25, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader i...	prnewswire...
08.12.2020	Emmaus Life Sciences Launches Endari® Support Program	TORRANCE, Calif., Dec. 8, 2020 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in...	prnewswire...
22.09.2019	Emmaus withdraws European application for sickle cell drug t...	Shares of Emmaus were down 9 percent Friday morning on the over-the-counter market and were down mor...	medcitynew...
20.09.2019	Emmaus rescinds EU marketing application, following...	Two years ago, Emmaus Life Sciences secured FDA approval for its sickle cell disease (SCD) the...	endpts.com...
-	Emmaus withdraws European application for sickle cell drug t...	A U.S. biotech company has withdrawn its application seeking approval for a drug to treat sickle cel...	medcitynew...